CRISPR Therapeutics AG - Company Profile
Powered by
All the data and insights you need on CRISPR Therapeutics AG in one report.
- Save hours of research time and resources with
our up-to-date CRISPR Therapeutics AG Strategy Report
- Understand CRISPR Therapeutics AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
CRISPR Therapeutics AG (CRISPR) is a gene editing company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human diseases. The company’s strategic partnerships, focus on research and development, and CRISPR/Cas9 technology enables it to improve its gene editing platform. Lack of marketed products brought a setback for the company. Strategic agreements, growing global medicines market and focus on developing engineered cell therapies for cancer immunotherapy can lead to the growth of the company. However, an intense competition faced by the company and healthcare reform in the US can affect the business of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer